SYNOVUS FINANCIAL CORP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$6,000
-14.3%
9500.0%0.00%
Q4 2016$7,000
-22.2%
9500.0%0.00%
Q3 2016$9,0000.0%9500.0%0.00%
Q2 2016$9,000
+12.5%
9500.0%0.00%
Q1 2016$8,000
+33.3%
9500.0%0.00%
Q4 2015$6,000
+20.0%
9500.0%0.00%
Q3 2015$5,000
-37.5%
9500.0%0.00%
Q2 2015$8,0009500.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Defender Capital, LLC. 581,100$2,324,0002.21%
Round Table Services, LLC 339,391$1,358,0000.52%
ARK Investment Management 1,885,641$7,543,0000.31%
WASATCH ADVISORS LP 5,337,930$21,352,0000.28%
Cedar Brook Financial Partners, LLC 41,500$166,0000.10%
Unified Trust Company, N.A. 13,716$54,0000.05%
Virtus ETF Advisers LLC 60,398$242,0000.04%
OXFORD ASSET MANAGEMENT LLP 394,703$1,579,0000.04%
FOX RUN MANAGEMENT, L.L.C. 14,465$58,0000.03%
BREWIN DOLPHIN LTD 59,123$236,4920.03%
View complete list of INOVIO PHARMACEUTICALS INC shareholders